14-day Premium Trial Subscription Try For FreeTry Free
$13.56
-0.180 (-1.31%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $12.20 $17.80 Wednesday, 1st May 2024 ENTA stock ended at $13.56. This is 1.31% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.63% from a day low at $13.51 to a day high of $14.27.
90 days $11.01 $17.80
52 weeks $8.08 $37.14

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
May 11, 2020 $51.56 $53.10 $51.56 $51.91 160 169
May 08, 2020 $51.99 $53.01 $50.76 $51.48 147 514
May 07, 2020 $54.04 $54.09 $50.57 $50.68 180 766
May 06, 2020 $51.84 $52.79 $50.96 $51.67 121 514
May 05, 2020 $51.64 $52.95 $50.27 $50.98 111 859
May 04, 2020 $47.34 $51.13 $46.39 $51.12 148 903
May 01, 2020 $45.70 $48.00 $44.90 $47.48 187 184
Apr 30, 2020 $48.57 $48.57 $46.36 $46.37 199 791
Apr 29, 2020 $51.03 $51.03 $48.57 $49.04 150 562
Apr 28, 2020 $54.78 $54.78 $50.03 $50.06 107 591
Apr 27, 2020 $54.37 $55.27 $53.98 $54.17 120 564
Apr 24, 2020 $52.63 $54.00 $52.05 $53.60 112 264
Apr 23, 2020 $53.99 $54.85 $52.33 $52.54 116 794
Apr 22, 2020 $54.25 $54.83 $52.89 $53.74 105 197
Apr 21, 2020 $54.68 $54.68 $52.29 $53.16 148 928
Apr 20, 2020 $54.05 $56.63 $53.50 $55.43 131 516
Apr 17, 2020 $55.01 $55.94 $54.50 $55.01 131 717
Apr 16, 2020 $52.98 $54.08 $52.37 $53.89 142 714
Apr 15, 2020 $52.38 $54.09 $52.38 $52.62 128 109
Apr 14, 2020 $53.53 $54.89 $53.41 $53.89 175 579
Apr 13, 2020 $52.45 $53.60 $51.77 $52.78 178 834
Apr 09, 2020 $53.16 $54.47 $52.31 $53.04 163 300
Apr 08, 2020 $51.23 $53.28 $50.60 $52.17 196 423
Apr 07, 2020 $51.77 $51.77 $49.10 $50.92 174 196
Apr 06, 2020 $51.33 $52.92 $48.97 $50.77 163 639
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT